Home/Filings/4/0000899243-20-008867
4//SEC Filing

Barclay Alec 4

Accession 0000899243-20-008867

CIK 0001492674other

Filed

Mar 17, 8:00 PM ET

Accepted

Mar 18, 4:48 PM ET

Size

7.6 KB

Accession

0000899243-20-008867

Insider Transaction Report

Form 4
Period: 2020-03-14
Barclay Alec
SVP, Operations
Transactions
  • Award

    Stock Option (Right to Buy)

    2020-03-14+130,000130,000 total
    Exercise: $0.40Exp: 2030-03-14Common Stock (130,000 underlying)
  • Award

    Restricted Stock Units

    2020-03-14+65,00065,000 total
    Common Stock (65,000 underlying)
Footnotes (3)
  • [F1]The stock option vests in 48 equal monthly installments commencing March 14, 2020.
  • [F2]Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
  • [F3]The restricted stock units vest in three equal annual installments commencing on March 14, 2021.

Issuer

T2 Biosystems, Inc.

CIK 0001492674

Entity typeother

Related Parties

1
  • filerCIK 0001734339

Filing Metadata

Form type
4
Filed
Mar 17, 8:00 PM ET
Accepted
Mar 18, 4:48 PM ET
Size
7.6 KB